It was to ensure that oral drugs reach patients and that they receive all the guidelines for safety in the use of chemotherapy, that the Oncoclínicas Group created DeLife. The proposal is to efficiently manage oral cancer drugs through an exclusive Patient Support Program (PSP), ensuring that patients receive the drug at home, being correctly oriented on its use.